🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

At Etiome, we build and apply detailed models of how biology shifts over the course of disease based on vast amounts of patient data, revealing new insights and opportunities to slow, stop or even prevent disease. Listen: bit.ly/4kGDB7F

Sail Biomedicines will present new preclinical data from our malaria vaccine program at the 𝟮𝟬𝟮𝟱 𝗚𝗿𝗮𝗻𝗱 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀 𝗔𝗻𝗻𝘂𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴, taking place June 1st to 4th virtually. The work highlights how our Endless RNA™ (eRNA™) platform may support more

It was a pleasure to host Congressman Jake Auchincloss (MA-04). He joined Flagship Founder & CEO Noubar Afeyan to welcome our newest class of summer Flagship Fellows and toured the labs at #FlagshipFounded companies Lila Sciences and Quotient Therapeutics to discuss how we’re pioneering

#FlagshipFounded Repertoire Immune Medicines welcomes Robert Andtbacka as Chief Medical Officer.

The Flagship team spent our 2025 Day of Service volunteering with nonprofit organizations — preparing food, packing kits for students, harvesting crops, sorting donated clothes, and more — to support their vital work in the Greater Boston community. #WeAreFlagship Thank you to

Flagship will be at #BIO2025 with innovators and leaders across the biotech industry to discuss what is ahead with AI applications, translating breakthrough science into the clinic, partnering with pharma, and more. Check out the panels that will feature leaders from Flagship and

"... the companies, the innovation, the scientists, the team members who are part of this incredible ecosystem, it makes me so optimistic about the future... and how these technologies and inventions are going to change people's lives all around the world." It was a pleasure to

Catch Flagship at #BIO2025 discussing what is ahead with AI applications, translating breakthrough science into the clinic, partnering with pharma, and more. Check out the panels that will feature leaders from Flagship and our ecosystem companies: bit.ly/4jHqBO0

Looking forward to speaking at the Milner Therapeutics Institute Symposium about polyintelligence and how #FlagshipFounded companies are pioneering a synthesis of human, machine, and nature’s intelligence. #MilnerSymp25 For more on polyintelligence: bit.ly/FlagshipPolyin…

Molly Gibson (Molly Gibson), Flagship Origination Partner and Co-Founder of #FlagshipFounded Generate:Biomedicines and Lila Sciences, discussed what’s working and what’s next in AI on a panel at #BIO2025. She was joined on stage by Luba Greenwood, Iya Khalil, Mary Rozenman, and Ricardo

Meet Bejan Mahmud, Associate at Pioneering Medicines — Flagship’s in house drug discovery and development unit. Bejan began his journey at Flagship as a Fellow, and now shares what drew him to the #FlagshipFellowship, what he's working on as part of the Product Concept Innovation

#FlagshipFounded ProFoundTx announces a collaboration with Novartis to discover and develop novel therapeutics for cardiovascular disease. For more: bit.ly/4kZgjua

We’re honored to be named again to the #THRIVETop50 by THRIVE AgriFood, spotlighting growth-stage companies setting a new standard for innovation across the ag value chain. Congrats to all the innovators on this year’s list. Read the full report: thriveagrifood.com/thrive-reports…

Noubar Afeyen, CEO and Founder of Flagship Pioneering, is now closing the Symposium with a fantastic talk on how human, nature and machine intelligence intersect to create Polyintelligence #MilnerSymp25

What is globin switching? In people with sickle cell disease, increasing fetal hemoglobin (HbF) can prevent red blood cells from sickling and blocking blood vessels. Reactivating HbF is a recognized therapeutic strategy that can significantly reduce disease burden. Globin

Meet Michael Smallegan, Associate, Machine Learning, in our ⏰ Off the Clock ⏰ series, as he shares his favorite yoga poses; how he empowers our companies to leverage AI/ML tools to pioneer new science; the possibilities he sees emerging with AI; and his favorite outdoor

#FlagshipFounded Valo Health is growing its team and pioneering partnerships to accelerate a human-centric, AI-enabled approach to drug discovery and development. Learn more about Valo’s vision for collaborative innovation in this Boston Business Journal piece.